thrombosis

Documents about thrombosis

• DOAC in Unusual Site Venous Thrombosis#1407723ClinicalTrials.gov
• Portal Vein Thrombosis in Cirrhosis#833670ClinicalTrials.gov
• Study on Inferior Vena Cava Thrombosis#1384860ClinicalTrials.gov
• Rivaroxaban Anticoagulation for Superficial Vein Thrombosis#1246465ClinicalTrials.gov
• Midlines and Thrombophlebitis#858242ClinicalTrials.gov
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters#829960ClinicalTrials.gov
• JETi Hong Kong Post Market Study (PMS)#869493ClinicalTrials.gov
• Upper Limb Thrombosis Associated With Midline Catheter#1198007ClinicalTrials.gov
• Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy#905536ClinicalTrials.gov
• Dabigatran Versus Apixaban in Cerebral Venous Thrombosis#1322817ClinicalTrials.gov
• Oral Rivaroxaban in Children With Venous Thrombosis#1214242ClinicalTrials.gov
• Impedance Plethysmography Based Deep Vein Thrombosis Monitoring During Catheter-directed Thrombolysis#802921ClinicalTrials.gov
• Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)#881053ClinicalTrials.gov
• API-CAT STUDY for APIxaban Cancer Associated Thrombosis#1152539ClinicalTrials.gov
• Outcomes in Patients With Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis#867382ClinicalTrials.gov
• What Treatment for Patients With Phlebitis or Pulmonary Embolism ?#1246993ClinicalTrials.gov
• Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis#1397452ClinicalTrials.gov
• Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)#864041ClinicalTrials.gov
• Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit#878935ClinicalTrials.gov
• Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis#880540ClinicalTrials.gov
• EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial#1418796ClinicalTrials.gov
• Heparin and the Reduction of Thrombosis (HART) Trial#874232ClinicalTrials.gov
• Portal Vein Thrombosis in Neonate With Umbilical Catheter#835254ClinicalTrials.gov
• Venous Thrombosis After Removal of Central Venous Catheter#1182325ClinicalTrials.gov
• Risk Factors for Thrombosis in Immune Thrombocytopenia#1310031ClinicalTrials.gov
• Staging and Prognosis of Deep Venous Thrombosis of Lower Extremities#804273ClinicalTrials.gov
• Optimal Duration of Anticoagulation in Deep Venous Thrombosis#865929ClinicalTrials.gov
• Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism#995624ClinicalTrials.gov
• Endovascular Therapy in Patients With Acute Deep Vein Thrombosis#870338ClinicalTrials.gov
• Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants#884834ClinicalTrials.gov
• Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis#913759ClinicalTrials.gov
• Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study#992172ClinicalTrials.gov
• Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV#1419031ClinicalTrials.gov
• PeriOperative ISchemic Evaluation-3 Trial#628607ClinicalTrials.gov
• ARIXTRA® Adherence in SVT Patients.#844125ClinicalTrials.gov
• Thrombosis and Neurocognition in Klinefelter Syndrome#864293ClinicalTrials.gov
• Study on Management Thrombosis in Greek Cancer Patients#994860ClinicalTrials.gov
• D-dimer and lower limb ultrasound as prognostic factors for recurrent deep venous thrombosis and pulmonary embolism: A systematic review and meta-analysis#187814PLOS
• Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis#861987ClinicalTrials.gov
• Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis#888536ClinicalTrials.gov
• The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis#865896ClinicalTrials.gov
• Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis#1164397ClinicalTrials.gov
• PREVENtion of HeartMate II Pump Thrombosis#1418564ClinicalTrials.gov
• Detection of Asymptomatic Venous Thrombosis in Gynecological Patients With Pelvic Masses#836714ClinicalTrials.gov
• Clinical Deterioration in Cerebral Venous Thrombosis: A Predictive Study#885705ClinicalTrials.gov
• COVID-19 and Deep Venous Thrombosis#1093875ClinicalTrials.gov
• Prevalence of Asymptomatic Thrombosis in Multiple Myeloma#1103330ClinicalTrials.gov
• AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System#1407162ClinicalTrials.gov
• Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis#981545ClinicalTrials.gov
• Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis#899511ClinicalTrials.gov